Robert W. Baldridge
Plus aucun poste en cours
Profil
Robert W.
Baldridge has been a Director of GTC Biotherapeutics, Inc. since 1994.
He provided consulting services to GTC Biotherapeutics from October 1994 to October 2000.
He has been an Independent Business Consultant since June 1988.
Mr. Baldridge was Chief Executive Officer and Chairman of TSI Corp.
from 1993 to 1994.
Anciens postes connus de Robert W. Baldridge
| Sociétés | Poste | Fin |
|---|---|---|
| REVO BIOLOGICS INC | Directeur/Membre du Conseil | 01/10/2009 |
| TSI Corp | Président | 01/01/1994 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| TSI Corp | Commercial Services |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |